Harry R. Trout III, See Remarks at ENANTA PHARMACEUTICALS INC (ENTA), sold 485 shares at $13.96 ($7K) on 2025-12-02, disclosed to the SEC on 2025-12-03.
Open-market sale of $7k ENTA by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.12 | 105 | $1K | 21.8% |
| 2 | $13.96 | 380 | $5K | 78.2% |
| Total | $13.99 avg | 485 | $7K | 100% |